Citigroup Downgrades Sabra Health Care REIT to Neutral From Buy, Cuts Price Target to $19 From $24
Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)